Tandem Diabetes Care Aktie [WKN DE: A1W8XG / ISIN: US8753721047]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Tandem Diabetes Care Inc

05.05.21		Tandem Diabetes Care Announces First Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance (Businesswire)
03.05.21		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
06.04.21		Tandem Diabetes Care to Announce First Quarter 2021 Financial Results on May 5, 2021 (Businesswire)
03.03.21		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
01.03.21		Tandem Diabetes Care Appoints Leading Artificial Pancreas Researcher Dr. Jordan Pinsker as Medical Director (Businesswire)
24.02.21		Tandem Diabetes Care Announces Fourth Quarter and Full Year 2020 Financial Results and 2021 Financial Guidance (Businesswire)
16.02.21		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
19.01.21		Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021 (Businesswire)
14.12.20		Tandem Diabetes Care Appoints Raj Sodhi to Board of Directors (Businesswire)
23.11.20		Tandem Diabetes Care Announces Health Canada Approval of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology (Businesswire)
05.11.20		Tandem Diabetes Care Announces Third Quarter 2020 Financial Results and Updated Full Year 2020 Sales Guidance (Businesswire)
30.10.20		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
08.10.20		Tandem Diabetes Care to Announce Third Quarter 2020 Financial Results on November 5, 2020 (Businesswire)
02.09.20		Tandem Diabetes Care Announces Upcoming Webcast Conference Presentations (Businesswire)
27.08.20		Tandem Diabetes Care Announces NEJM Publication of Pediatric Study Demonstrating Increased Time-In-Range using the t:slim X2 Insulin Pump with Control-IQ Technology (Businesswire)
29.07.20		Tandem Diabetes Care Appoints Peyton Howell to Board of Directors (Businesswire)
09.07.20		Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement (Businesswire)
08.07.20		JDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D Community (Businesswire)
07.07.20		Tandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020 (Businesswire)
24.06.20		Tandem Diabetes Care Acquires Sugarmate, a Popular Mobile App for People with Diabetes (Businesswire)
17.06.20		Tandem Diabetes Care Announces Expanded Pediatric Indication of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology (Businesswire)
13.06.20		Tandem Diabetes Care Presents Positive Real-world Data from Automated Insulin Delivery Systems at American Diabetes Association Scientific Sessions (Businesswire)
04.06.20		Tandem Diabetes Care Appoints Dr. Kathleen McGroddy-Goetz to Board of Directors (Businesswire)
29.05.20		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
18.05.20		Tandem Diabetes Care to Hold Virtual-Only 2020 Annual Meeting of Stockholders (Businesswire)
13.05.20		Tandem Diabetes Care Announces Pricing of $250.0 Million of Convertible Senior Notes Due 2025 (Businesswire)
12.05.20		Tandem Diabetes Care Announces Proposed Offering of $250.0 Million of Convertible Senior Notes Due 2025 (Businesswire)
07.05.20		Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
30.04.20		Tandem Diabetes Care Announces First Quarter 2020 Financial Results (Businesswire)
09.04.20		Tandem Diabetes Care to Announce First Quarter 2020 Financial Results on April 30, 2020 (Businesswire)
16.03.20		Tandem Diabetes Care Announces Security Incident with Five Employee Email Accounts (Businesswire)
02.03.20		Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller (Businesswire)
24.02.20		Tandem Diabetes Care Announces Fourth Quarter and Full Year 2019 Financial Results and 2020 Financial Guidance (Businesswire)
14.02.20		Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
27.01.20		Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020 (Businesswire)
15.01.20		Tandem Diabetes Care Announces Commercial Launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States (Businesswire)
09.01.20		Tandem Diabetes Care Appoints New Executive Vice President of Strategy and Corporate Development (Businesswire)
13.12.19		Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology (Businesswire)
20.11.19		Tandem Diabetes Care Announces Health Canada Approval of t:slim X2 Insulin Pump with Basal-IQ Predictive Low-Glucose Suspend Technology (Businesswire)
01.11.19		2019 Beyond Type Run Team to Race the TCS New York City Marathon Using Basal-IQ Technology from Tandem Diabetes Care (Businesswire)
30.10.19		Tandem Diabetes Care Presents Positive Real-World Data from Pediatric Users of t:slim X2 Insulin Pump with Basal-IQ Technology at International Conference (Businesswire)
16.10.19		Tandem Diabetes Care Announces NEJM Publication of Landmark Study Demonstrating Increased Time-In-Range with the t:slim X2 Insulin Pump with Control-IQ Technology (Businesswire)
14.10.19		Tandem Diabetes Care to Announce Third Quarter 2019 Financial Results on November 4, 2019 (Businesswire)
18.09.19		Tandem Diabetes Care Announces Publication of Real-world Basal-IQ Predictive Low Glucose Suspend Technology Data in Diabetes Technology and Therapeutics Journal (Businesswire)
29.08.19		Tandem Diabetes Care Announces Upcoming Conference Participation and Presentations (Businesswire)
01.08.19		Tandem Diabetes Care Announces Second Quarter 2019 Financial Results and Updated 2019 Financial Guidance (Businesswire)
01.08.19		Tandem Diabetes Care Announces No-Cost Software Updates for t:slim X2 Insulin Pump Customers in the United States (Businesswire)
19.07.19		Tandem Diabetes Care to Announce Second Quarter 2019 Financial Results on August 1, 2019 (Businesswire)
20.06.19		Tandem Diabetes Care Announces Upcoming Conference Presentation (Businesswire)
10.06.19		Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology (Businesswire)

Zurück | 1 | 2 | 3 | Weiter

Newssuche

Meistgelesene Nachrichten

Pierer-Aktie letztlich zweistellig höher: KTM ist insolvent - Antrag auf Sanierung in Eigenverwaltung

Ripple steigt deutlich: Neues ATH noch in 2024?

Strategische Bitcoin-Reserve: USA erwägen milliardenschweren Bitcoin-Kauf

Solana Kurs Prognose: 300 US-Dollar noch in diesem Jahr?

Novo Nordisk-Aktien und Eli Lilly-Papiere crashen: Ist der Erfolgstraum ausgträumt?

VW-Aktie unter Druck: Flächendeckender Streik bei Volkswagen - Tausende Jobs in Österreich abhänging

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	03.12.2024 12:49
Kaufwert:	EUR
	Hinzufügen Speichern